Literature DB >> 11528001

Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.

J Overbaugh1, A D Miller, M V Eiden.   

Abstract

In the past few years, many retrovirus receptors, coreceptors, and cofactors have been identified. These molecules are important for some aspects of viral entry, although in some cases it remains to be determined whether they are required for binding or postbinding stages in entry, such as fusion. There are certain common features to the molecules that many retroviruses use to gain entry into the cell. For example, the receptors for most mammalian oncoretroviruses are multiple membrane-spanning transport proteins. However, avian retroviruses use single-pass membrane proteins, and a sheep retrovirus uses a glycosylphosphatidylinositol-anchored molecule as its receptor. For some retroviruses, particularly the lentiviruses, two cell surface molecules are required for efficient entry. More recently, a soluble protein that is required for viral entry has been identified for a feline oncoretrovirus. In this review, we will focus on the various strategies used by mammalian retroviruses to gain entry into the cell. The choice of receptors will also be discussed in light of pressures that drive viral evolution and persistence.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11528001      PMCID: PMC99032          DOI: 10.1128/MMBR.65.3.371-389.2001

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  197 in total

1.  Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5.

Authors:  C K Lapham; M B Zaitseva; S Lee; T Romanstseva; H Golding
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

2.  The human homologue of the bovine leukemia virus receptor BLVRcp1 is the delta-subunit of adaptor-related AP-3 protein that does not bind the BVLgp51.

Authors:  J Ban; J Hlavaty; O Orlik; G A Splitter; C Altaner
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

3.  Expression cloning of new receptors used by simian and human immunodeficiency viruses.

Authors:  H K Deng; D Unutmaz; V N KewalRamani; D R Littman
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

4.  Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains.

Authors:  A L Edinger; A Amedee; K Miller; B J Doranz; M Endres; M Sharron; M Samson; Z H Lu; J E Clements; M Murphey-Corb; S C Peiper; M Parmentier; C C Broder; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry.

Authors:  Z Chen; P Zhou; D D Ho; N R Landau; P A Marx
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo.

Authors:  S Pöhlmann; N Stolte; J Münch; P Ten Haaft; J L Heeney; C Stahl-Hennig; F Kirchhoff
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

7.  Identification of amino acid residues critical for infection with ecotropic murine leukemia retrovirus.

Authors:  T Yoshimoto; E Yoshimoto; D Meruelo
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

8.  Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infections.

Authors:  C S Tailor; Y Takeuchi; B O'Hara; S V Johann; R A Weiss; M K Collins
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Modulation of ecotropic murine retroviruses by N-linked glycosylation of the cell surface receptor/amino acid transporter.

Authors:  H Wang; E Klamo; S E Kuhmann; S L Kozak; M P Kavanaugh; D Kabat
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

View more
  76 in total

1.  Host range and receptor binding properties of vectors bearing feline leukemia virus subgroup B envelopes can be modulated by envelope sequences outside of the receptor binding domain.

Authors:  Peggy Ho Faix; Steven A Feldman; Julie Overbaugh; Maribeth V Eiden
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Primate gammaretroviruses require an ancillary factor not required for murine gammaretroviruses to infect BHK cells.

Authors:  Wenqin Xu; Maribeth V Eiden
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  Early- and intermediate-stage variants of simian immunodeficiency virus replicate efficiently in cells lacking CCR5.

Authors:  Serene Forte; Mary-Elizabeth Harmon; Mario J Pineda; Julie Overbaugh
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.

Authors:  Virginie Sandrin; Delphine Muriaux; Jean-Luc Darlix; François-Loïc Cosset
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 5.  Gene therapy: light is finally in the tunnel.

Authors:  Huibi Cao; Robert S Molday; Jim Hu
Journal:  Protein Cell       Date:  2012-01-10       Impact factor: 14.870

6.  Expression levels of the PiT-2 receptor explain, in part, the gestational age-dependent alterations in transduction efficiency after in utero retroviral-mediated gene transfer.

Authors:  Ferhat Ozturk; Paul J Park; Joseph Tellez; Evan Colletti; Maribeth V Eiden; Graça Almeida-Porada; Christopher D Porada
Journal:  J Gene Med       Date:  2012-03       Impact factor: 4.565

7.  Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo.

Authors:  Yung-Wei Pan; Jarrad M Scarlett; Tammy T Luoh; Peter Kurre
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

8.  Envelope determinants for dual-receptor specificity in feline leukemia virus subgroup A and T variants.

Authors:  Heather H Cheng; Maria M Anderson; F Claire Hankenson; Lily Johnston; Chitra V Kotwaliwale; Julie Overbaugh
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

9.  Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein.

Authors:  Yuanming Zhang; John C Rassa; Maria Elena deObaldia; Lorraine M Albritton; Susan R Ross
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.

Authors:  Sandra Blaise; Nathalie de Parseval; Laurence Bénit; Thierry Heidmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.